Psyence Biomedical PBM
NASDAQ PBM
$3.93 -0.17 (-4.15%)
At close: Aug 20, 2026 · 4:00 PM EDT

Psyence Biomedical Ltd. (PBM) Debt Ratio (2023 - 2025)

Psyence Biomedical (PBM) posted quarterly Debt Ratio of 0.02 for Q3 2025, down 95.81% year-over-year from 0.56 in Q3 2024, and down 14.84% quarter-over-quarter from 0.03 in Q1 2025.

Psyence Biomedical Ltd. (PBM) Debt Ratio (2023 - 2025) Analysis & Trends

Psyence Biomedical's Debt Ratio history runs 3 years deep, the most recent figure standing at 0.02 for Q3 2025.

  • In Q3 2025, Debt Ratio fell 95.81% year-over-year to 0.02; the TTM figure through Sep 2025 stood at 0.02 (down 95.81% YoY), while the FY2025 annual figure was 0.03, down 97.9% from the prior year.
  • Debt Ratio for Q3 2025 stood at 0.02, down from 0.03 in the prior quarter.
  • The five-year high for Debt Ratio was 126788591968.2 in Q3 2023, with the low at 0.02 in Q3 2025.
  • The 3-year median for Debt Ratio is 0.56 (2024), against an average of 25357718394.02.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio plunged 100.0% in 2024, then plunged 95.81% in 2025.
  • Psyence Biomedical's Debt Ratio stood at 126788591968.2 in 2023, then tumbled by 100.0% to 0.56 in 2024, then slumped by 95.81% to 0.02 in 2025.
  • Business Quant data shows PBM's Debt Ratio at 0.02 in Q3 2025, 0.03 in Q1 2025, and 0.56 in Q3 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 0.02
Mar 31, 2025 0.03
Sep 30, 2024 0.56
Mar 31, 2024 1.30
Sep 30, 2023 126.79 Bn